221 related articles for article (PubMed ID: 9742213)
1. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
Sandy JD; Gamett D; Thompson V; Verscharen C
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
[TBL] [Abstract][Full Text] [Related]
2. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid.
Sandy JD; Thompson V; Verscharen C; Gamett D
Arch Biochem Biophys; 1999 Jul; 367(2):258-64. PubMed ID: 10395742
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
Lark MW; Gordy JT; Weidner JR; Ayala J; Kimura JH; Williams HR; Mumford RA; Flannery CR; Carlson SS; Iwata M
J Biol Chem; 1995 Feb; 270(6):2550-6. PubMed ID: 7852317
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
[TBL] [Abstract][Full Text] [Related]
5. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.
Sandy JD; Thompson V; Doege K; Verscharen C
Biochem J; 2000 Oct; 351(Pt 1):161-6. PubMed ID: 10998358
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.
Sztrolovics R; White RJ; Roughley PJ; Mort JS
Biochem J; 2002 Mar; 362(Pt 2):465-72. PubMed ID: 11853556
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage.
Ilic MZ; Martinac B; Handley CJ
Osteoarthritis Cartilage; 2003 Aug; 11(8):613-22. PubMed ID: 12880584
[TBL] [Abstract][Full Text] [Related]
8. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.
Patwari P; Kurz B; Sandy JD; Grodzinsky AJ
Arch Biochem Biophys; 2000 Feb; 374(1):79-85. PubMed ID: 10640399
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase.
Arner EC; Decicco CP; Cherney R; Tortorella MD
J Biol Chem; 1997 Apr; 272(14):9294-9. PubMed ID: 9083065
[TBL] [Abstract][Full Text] [Related]
10. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay.
Buttle DJ; Fowles A; Ilic MZ; Handley CJ
Mol Pathol; 1997 Jun; 50(3):153-9. PubMed ID: 9292151
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
13. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
14. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
16. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Arthritis Rheum; 2000 Oct; 43(10):2211-8. PubMed ID: 11037880
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.
Mercuri FA; Doege KJ; Arner EC; Pratta MA; Last K; Fosang AJ
J Biol Chem; 1999 Nov; 274(45):32387-95. PubMed ID: 10542281
[TBL] [Abstract][Full Text] [Related]
18. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
[TBL] [Abstract][Full Text] [Related]
19. Effects of proteinase inhibitors on aggrecan catabolism in chondrocyte cultures.
Flannery CR; Sandy JD
Ann N Y Acad Sci; 1994 Sep; 732():380-3. PubMed ID: 7978815
[No Abstract] [Full Text] [Related]
20. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
